Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced ...
Tag: Health care industry
Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding
Prenuvo's clinic in New York City, New York.Courtesy of PrenuvoPreventative health startup Prenuvo on Thursday announced it will offer three ...
Neuralink competitor Paradromics secures investment from Saudi Arabia’s Neom
Paradromics' Connexus Direct Data Interface.Courtesy: ParadromicsTexas-based neurotech startup Paradromics on Wednesday announced a strategic partnership with Saudi Arabia's Neom and ...
Doximity shares soar 25% after company beats on revenue, raises fiscal-year guidance
Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021.Source: NYSEShares of Doximity popped ...
Doximity shares pop 36% on revenue beat, rosy guidance
Piotr Swat | Lightrocket | Getty ImagesDoximity shares closed up 36% on Friday, a day after the company reported fiscal ...
Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients
Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that's slated to run ...
Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
Shana Novak | Stone | Getty ImagesPresident Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug ...
RFK Jr. stumbles over basics of Medicare, Medicaid during Senate confirmation hearings
Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate ...
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the ...
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International Finance (IIF) during the annual ...
